Single-site video endoscopic inguinal lymphadenectomy: initial report.

No prior work had resolved the optimal balance between surgical access and patient recovery for groin node removal. Conventional laparoscopic approaches often require multiple incisions, which can impact cosmetic outcomes and healing. That uncertainty drove the development of single-incision platforms to minimize tissue disruption. It was already known that traditional video-assisted methods provide effective oncologic control for penile cancer. However, surgeons continue seeking ways to reduce postoperative morbidity while maintaining high standards of care. This gap motivated the exploration of novel access strategies in urologic oncology. Prior research has shown that single-site surgery is feasible in other abdominal procedures. This study addresses whether these benefits translate to inguinal lymph node management.

This report aims to document the initial experience with a novel single-incision approach for groin node removal. The authors sought to determine if this method could provide similar oncologic results to established techniques. They specifically investigated whether reducing the number of incisions would improve cosmetic satisfaction for the patient. The study addresses the challenge of balancing surgical access with the desire for less invasive procedures. Researchers were motivated by the ongoing evolution of minimally invasive urologic surgery. They aimed to provide a preliminary assessment of technical feasibility in a clinical setting. This work serves as a foundation for future comparative research into surgical refinement. The primary goal was to establish whether this modification maintains the safety profile of traditional video-assisted lymphadenectomy.

The authors conducted a preliminary clinical assessment comparing two distinct surgical access strategies. They performed a unilateral single-incision procedure alongside a standard multi-port video-assisted operation on one patient. This design allowed for a direct intra-patient comparison of technical feasibility and recovery metrics. The team utilized specialized endoscopic equipment to facilitate node dissection through a restricted entry point. They monitored operative duration, hemorrhage levels, and fluid drainage throughout the intervention. The researchers also tracked the total number of lymph nodes successfully harvested from each groin. Patient-reported satisfaction regarding the final appearance of the surgical site was documented post-recovery. This review approach synthesized these observations to determine if the novel method matches established standards.

The primary finding indicates that the single-incision approach achieves equivalent node retrieval compared to the standard multi-port method. Both techniques successfully harvested 8 lymph nodes during the procedure. Hemorrhage levels were identical, with both methods resulting in 50 mL of blood loss. Operative duration for the single-site method was 120 minutes, while the conventional approach required 100 minutes. Drainage volume and postoperative pain levels showed no significant disparity between the two surgical strategies. The patient experienced a smooth recovery and was discharged 12 hours after the operation. Most importantly, the individual expressed a clear preference for the cosmetic outcome of the single-site incision. These results suggest that the novel technique provides comparable clinical efficacy while enhancing patient satisfaction.

The authors propose that the single-site approach offers a viable alternative for managing inguinal nodes. Clinical data suggest that operative duration and node yield remain comparable to standard multi-port methods. Patient preference favored the aesthetic outcome of the single-incision procedure over the traditional technique. The researchers emphasize that current technical challenges may be mitigated by future hardware improvements. Synthesis of these findings indicates that oncologic safety remains the primary priority for clinical adoption. The authors suggest that rigorous comparative trials are required to validate these preliminary observations. Future integration of robotic platforms might enhance the precision and accessibility of this surgical modality. Widespread implementation depends on demonstrating consistent long-term oncologic success across larger patient cohorts.